Erenumab in the prevention of high‐frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real‐life study-Reference-Cited by-同舟云学术

Erenumab in the prevention of high‐frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real‐life study

Published:2020-12-18 Issue:2 Volume:61 Page:363-372
ISSN:0017-8748
Container-title:Headache: The Journal of Head and Face Pain
language:en
Short-container-title:Headache: The Journal of Head and Face Pain

Author:

Barbanti Piero¹²,Aurilia Cinzia¹,Egeo Gabriella¹,Fofi Luisa¹,Cevoli Sabina³,Colombo Bruno⁴,Filippi Massimo⁴,Frediani Fabio⁵,Bono Francesco⁶,Grazzi Licia⁷,Salerno Antonio⁸,Mercuri Bruno⁸,Carnevale Antonio⁹,Altamura Claudia¹⁰^ORCID,Vernieri Fabrizio¹⁰

Affiliation:

1. Headache and Pain Unit IRCCS San Raffaele Pisana Rome Italy

2. San Raffaele University Rome Italy

3. IRCCS Istituto delle Scienze Neurologiche Bologna Italy

4. Neurology Unit IRCCS San Raffaele Scientific Institute, Vita‐Salute San Raffaele University Milan Italy

5. Headache Center ASST Santi Paolo Carlo Milan Italy

6. Center for Headache and Intracranial Pressure Disorders Neurology Unit, A.O.U. Mater Domini Catanzaro Italy

7. Neuroalgology Unit Headache Center Fondazione IRCCS Istituto Neurologico “Carlo Besta” Milan Italy

8. San Giovanni Addolorata Hospital Rome Italy

9. San Filippo Neri Hospital Rome Italy

10. Headache and Neurosonology Unit Policlinico Universitario Campus Bio‐Medico Rome Italy

Publisher